Group items tagged

By identifying the structure of DNA, the molecule of life, Francis Crick and James Watson revolutionized biochemistry and won themselves a Nobel Prize. At the time, Watson was only twenty-four, a young scientist hungry to make his mark. His uncompromisingly honest account of the heady days of their thrilling sprint against other world-class researchers to solve one of science's greatest mysteries gives a dazzlingly clear picture of a world of brilliant scientists with great gifts, very human ambitions, and bitter rivalries. With humility unspoiled by false modesty, Watson relates his and Crick's desperate efforts to beat Linus Pauling to the Holy Grail of life sciences, the identification of the basic building block of life. Never has a scientist been so truthful in capturing in words the flavor of his work.

Rebecca Debens, Scrip Reporter, visits Ontario to find out more about Ontario's growing life science industry and the Canadian government schemes encouraging and supporting businesses. The article features MaRS and describes how MaRS has become the "hub of Canada's life sciences cluster."

Rebecca Debens, Scrip Reporter, visits Ontario to find out more about Ontario's growing life science industry and the Canadian government schemes in encouraging and supporting businesses. The article features MaRS and describes how MaRS has become the "hub of Canada's life sciences cluster." Jun 3, 2009

"Governor Pat Quinn is visiting Canada re: economic development and promoting Illinois' trade and business opportunities, as well as tourism and life sciences industries.Governor Quinn also met with key members of the life sciences and bio-energy communities at a meeting hosted by MaRS Innovation and MaRS Discovery District at the MaRS Centre."

The MedEdge Life Sciences Business Summit will be taking place on June 14th, 2012 at the Richmond Hill Centre for the Performing Arts which will take a look at how to enter the healthcare market and understand the procurement process. Dr Usha Srinivasan, Program Director, Business Acceleration Program (BAP), MaRS Discovery District will be speaking at the event.

Ontario announced a new fund to attract and retain world-leading genomics researchers in the province.The $100-million Global Leadership Round in Genomics and Life Sciences will support globally-significant, collaborative research projects that are headquartered in Ontario. Dr. Evans is quoted stating that "the government must recognize that Ontario must invest in strong life science clusters."

Ontario announced a new fund to attract and retain world-leading genomics researchers in the province.The $100-million Global Leadership Round in Genomics and Life Sciences will support globally-significant, collaborative research projects that are headquartered in Ontario. Dr. Evans is quoted stating that "the government must recognize that Ontario must invest in strong life science clusters."

"Jack Stewart a biotechnology entrepreneur, is about to start a human trial for a drug developed from a compound found in shrew spit that could treat ovarian, breast and prostate cancers without many of the side effects of chemotherapy." Veronika Litinski, a Senior Advisor at MaRS in the Life Science and Health care practice says it is difficult to run trials with a clear robust criteria.

MaRS life sciences and health care practice client, Dr. Hamid Tizhoosh, founder of Segasist, is interviewed for CityNews. He talks about how he became and entrepreneur and how this shapes his life.

Calgary ranks as the number one spot in terms of quality of life according to the new poll commissioned for CityAge Media's The Innovation City Summit. The summit will take place at the MaRS Centre, on July 18 & 19.

MaRS Discovery District has selected Alexandria Real Estate Equities Inc, the largest publicly traded U.S. life science realty company, to develop a 900,000 square foot high-rise office and laboratory complex that will include an of the atrium in the MaRS building. Jun 27, 2007

MaRS Discovery District has selected Alexandria Real Estate Equities Inc, the largest publicly traded U.S. life science realty company, to develop a 900,000 square foot high-rise office and laboratory complex that will include an of the atrium in the MaRS building.

Vincent Cheung of Shape Collage, a MaRS client, has been named the 2010 student entrepreneur Ontario champion and regional champion for Ontario and Quebec by the national charitable organization Advancing Canadian Entrepreneurship (ACE). Read this online discussion with him on the Globe and Mail about being a student entrepreneur.

LidiasWorld blogs about the Entrepreneurship 101 class she and her partner attended at MaRS with guest speaker Dr. Stuart Foster, the founder of VisualSonics, spoke mainly about the challenges of being a science tech specific startup.

"MaRS Innovation (MI), The Hospital for Sick Children (SickKids) and NovoTek Therapeutics Inc. (NovoTek, Beijing/China) have announced a strategic partnership to co-develop a therapeutic cream aimed at reducing scar formation post surgery."

CHALLENGE: It's got potential and is ready to be built, but is the science sound? And can a fringe medical treatment have mass appeal?

Lew Lim founder of Mediclights is a MaRS client and is bringing intranasal light therapy to Canada. Peter Adams, a MaRS Life Science and Healthcare IT advisor is working with Lim to commercializing this innovation. They would like to see Toronto as the new hub for interanasal laser research.

MaRS' Investment Accelerator Fund is looking to invest in information technology, cleantech, advanced materials, manufacturing and life sciences early-stage growth companies. There is a separate fund of $7 million in funding announced for just life sciences

According to an Angus Reid public opinion poll, Calgary is reported to have the best quality of life out of Canada's four largest cities. Acording to Jane Switzer, a report from The Globe and Mail, the "Angus Reid poll was commissioned for CityAge Media's The Innovation City summit." The summit will take place at the MaRS Centre, July 18 and 19th and will explore the new ideas, technologies and partnerships that will build the 21st century city, and why - and how - Metro Toronto and Canada will be a leader in this urban century.

There is a need for enhancing commercialization, but there are gaps particularly in the lifesciences. Dr. Calvin Stiller, MaRS Board member states that there is a difference it testing and approval times in the commercialization of life sciences that still needs to be addressed.

The Ontario Genomics Institute (OGI) teamed up with Invitrogen Corporation, a California-based global leader in providing life sciences technology, recently to host Genome 2.0: New Frontiers in Epigenomics, a one-day symposium addressing epigenetic regulation of gene expression with a special focus on chromatin biology, DNA methylation, non-coding RNAs and technology development.

MaRS Innovation (MI) has signed a co-funding agreement with the Johnson & Johnson Corporate Office of Science and Technology to capitalize and accelerate the use of Toronto-based life-sciences technologies during the early stages of pharmaceutical and medical device development.

Outlines Event schedule for Toronto Innovation Forum June 16, 2009 Program "Opportunity, Creativity and Partnership"

Outlines Event schedule for Toronto Innovation Forum June 16, 2009 Program "Opportunity, Creativity and Partnership." Veronika Litinski, Practice Lead, Healthcare and Life Sciences, MaRS will talk about Best Practices in Venture Creation.